You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5

Article metrics

Article menu

Download PDFPDF

Research Article
Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2024

AbstractFullPdf
Dec 2019220
Jan 2020440
Feb 202010101
Mar 202015151
Apr 2020770
May 202011113
Jun 2020990
Jul 202010100
Aug 2020882
Sep 202020204
Oct 202017170
Nov 2020991
Dec 2020993
Jan 202114144
Feb 2021882
Mar 202112121
Apr 2021440
May 2021883
Jun 202112121
Jul 2021663
Aug 2021551
Sep 2021994
Oct 202113134
Nov 2021774
Dec 202112121
Jan 202212132
Feb 202210100
Mar 202212135
Apr 202219203
May 202222232
Jun 202223232
Jul 202224252
Aug 202235354
Sep 202227272
Oct 202215153
Nov 2022798
Dec 202215153
Jan 202312122
Feb 202325252
Mar 2023565
Apr 2023449
May 202311114
Jun 202311121
Jul 202311118
Aug 202312121
Sep 202316161
Oct 202387882
Nov 20231831831
Dec 202312122
Jan 202410112
Feb 2024661
Mar 202410102
Apr 202412122
May 202418182
Jun 202429286
Jul 202427288
Aug 202421207
Total984994147